Ratchaphruek Hospital PCL (BKK:RPH)
Thailand · Delayed Price · Currency is THB 4.880
+0.020 (0.41%)
Sep 25, 2026, 4:35 PM ICT
Ratchaphruek Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,136 | 1,162 | 1,125 | 1,161 | 1,326 | 1,413 | |
Revenue Growth | -1.04% | 3.27% | -3.05% | -12.49% | -6.12% | 76.72% |
Cost of Revenue | 771.13 | 771.53 | 751.44 | 750.58 | 827.01 | 746.98 |
Gross Profit | 364.76 | 390.47 | 373.73 | 410.01 | 499.17 | 665.58 |
Selling, General & Admin | 189.44 | 184.67 | 181.22 | 191.46 | 149.5 | 167.72 |
Other Operating Expenses | -20.65 | -21.6 | -17.85 | - | - | - |
Operating Expenses | 168.79 | 163.07 | 163.36 | 191.46 | 149.5 | 167.72 |
Operating Income | 195.97 | 227.41 | 210.37 | 218.55 | 349.67 | 497.86 |
Interest Expense | -0.43 | -0.51 | -0.57 | -2.11 | -5.55 | -6.69 |
Interest & Investment Income | 4.14 | 4.14 | 6.58 | 2.78 | 0.81 | 0.35 |
Other Non Operating Income (Expenses) | - | - | - | 14.16 | 13.26 | 11.54 |
EBT Excluding Unusual Items | 199.67 | 231.03 | 216.37 | 233.38 | 358.19 | 503.07 |
Pretax Income | 199.67 | 231.03 | 216.37 | 233.38 | 358.19 | 503.07 |
Income Tax Expense | 41.61 | 48.66 | 43.84 | 48.92 | 71.73 | 100.07 |
Net Income | 158.06 | 182.37 | 172.53 | 184.45 | 286.47 | 402.99 |
Net Income to Common | 158.06 | 182.37 | 172.53 | 184.45 | 286.47 | 402.99 |
Net Income Growth | -11.63% | 5.70% | -6.46% | -35.61% | -28.92% | 329.43% |
Shares Outstanding (Basic) | 530 | 533 | 546 | 546 | 546 | 546 |
Shares Outstanding (Diluted) | 530 | 533 | 546 | 546 | 546 | 546 |
Shares Change | -1.97% | -2.33% | -0.01% | - | - | - |
EPS (Basic) | 0.30 | 0.34 | 0.32 | 0.34 | 0.52 | 0.74 |
EPS (Diluted) | 0.30 | 0.34 | 0.32 | 0.34 | 0.52 | 0.74 |
EPS Growth | -9.85% | 8.22% | -6.46% | -35.61% | -28.92% | 329.43% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 50.76 | 164.69 | 230.62 | 342.38 | 420.32 | 271.25 |
Free Cash Flow Per Share | 0.10 | 0.31 | 0.42 | 0.63 | 0.77 | 0.50 |
Dividend Per Share | 0.260 | 0.280 | 0.290 | 0.300 | 0.350 | 0.300 |
Dividend Growth | -7.14% | -3.45% | -3.33% | -14.29% | 16.67% | 130.77% |
Gross Margin | 32.11% | 33.60% | 33.22% | 35.33% | 37.64% | 47.12% |
Operating Margin | 17.25% | 19.57% | 18.70% | 18.83% | 26.37% | 35.24% |
Profit Margin | 13.91% | 15.70% | 15.33% | 15.89% | 21.60% | 28.53% |
Free Cash Flow Margin | 4.47% | 14.17% | 20.50% | 29.50% | 31.69% | 19.20% |
EBITDA | 272.92 | 302.14 | 284.77 | 303.46 | 440.29 | 584.49 |
EBITDA Margin | 24.03% | 26.00% | 25.31% | 26.15% | 33.20% | 41.38% |
D&A For EBITDA | 76.95 | 74.73 | 74.4 | 84.91 | 90.62 | 86.62 |
EBIT | 195.97 | 227.41 | 210.37 | 218.55 | 349.67 | 497.86 |
EBIT Margin | 17.25% | 19.57% | 18.70% | 18.83% | 26.37% | 35.24% |
Effective Tax Rate | 20.84% | 21.06% | 20.26% | 20.96% | 20.02% | 19.89% |